Hinova Pharmaceuticals, Inc. Class ASSE: 688302

Announcement on Convening the Q1 2025 Performance Briefing

May 27, 2025 · Issued by Hinova Pharmaceuticals, Inc. Class A via Shanghai Stock Exchange

Announcement on Convening the Q1 2025 Performance Briefing

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment